Brief: Agenus Unveils New And Updated Botensilimab Data In Colorectal, Pancreatic, Lung, Melanoma, And Sarcoma
22/10/2023 17:03
Oct 22 (Reuters) - Agenus Inc AGEN.O :
* AGENUS UNVEILS NEW AND UPDATED BOTENSILIMAB DATA IN
COLORECTAL,
PANCREATIC, LUNG, MELANOMA, AND SARCOMA
* U.S. BLA FILING IN MICROSATELLITE STABLE (MSS) METASTATIC
COLORECTAL CANCER (CRC) PLANNED FOR MIDYEAR 2024
* POTENTIAL ACCELERATED FILINGS FOR ADVANCED PANCREATIC
CANCER AND
MELANOMA IN 2025
Source text for Eikon: ID:nBw6mDHhWa
Further company coverage: AGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income